ClinicalTrials.Veeva

Menu

Antimicrobial Resistance in Cirrhotic Patients

M

Mansoura University

Status

Unknown

Conditions

Cirrhosis

Treatments

Diagnostic Test: Specimen

Study type

Observational

Funder types

Other

Identifiers

NCT04915573
34647/4/21

Details and patient eligibility

About

Cirrhotic patients are more vulnerable to bacterial infection, and infection is one of the most common causes of acute liver disease decompensation.

Full description

Cirrhotic patients are more vulnerable to bacterial infection which is a common cause of acute liver disease decompensation. The aim of this study will characterize the antimicrobial resistance and distribution of bacteria isolated from chronic hepatic patients with pulmonary infections, as well as to evaluate the antimicrobial susceptibility of bacteria isolated from sputum.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Adults' older than 18 years with clinical evidence of liver disease

Exclusion criteria

  1. Pregnancy
  2. Intensive care unite stay of more than 24 hours
  3. Malignancy
  4. Organ transplantation
  5. Acquired immune deficiency syndrome

Trial design

100 participants in 1 patient group

patients with Cirrhosis
Description:
Patient with clinical evidence of liver disease, portal hypertension, ultrasound or computed tomography results, laboratory data will be used to confirm liver disease
Treatment:
Diagnostic Test: Specimen

Trial contacts and locations

1

Loading...

Central trial contact

Noha Mansour, Ph.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems